Log In or Register to Join The Conversation!
  • This topic is empty.
Viewing 0 reply threads
  • Author
    • #20131

      We currently have a study in Canada for patients with Relapsing-Remitting Multiple Sclerosis (RRMS). We want to learn about the gastrointestinal side effects of oral disease-modifying treatments (DMTs) such as Aubagio. We are looking for patients who have been diagnosed with RRMS and have experienced gastrointestinal related symptoms while taking one of those medications, either currently or within the last 12 weeks. You may be currently taking one of these medications or might have discontinued taking the medication – we are interested in both sides.

      If you qualify for this study, you will be asked to participate in a telephone interview lasting around 60-90 minutes. Eligible participants who participate in the interview will receive $275 CAD ($200 CAD for participation and $75 CAD for providing confirmation of diagnosis) If you or someone you know has a diagnosis of relapsing-remitting multiple sclerosis and have experienced gastrointestinal adverse events from treatment and are interested in participating or would like more information about the study, please contact me at [email protected]

      Many thanks!

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account